Natera, Inc.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
13011 MCCALLEN PASS, AUSTIN, TX, 78753
Mailing Address
13011 MCCALLEN PASS, AUSTIN, TX, 78753
Phone
650-249-9090
Fiscal Year End
1231
EIN
010894487
Financial Overview
FY2025
$2.40B
Total Assets
$685.93M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
| 4 Insider stock transaction report | March 11, 2026 | View on SEC |
Annual Reports
10-K
February 27, 2026
- Achieved strong revenue growth of 28% to $1.15 billion in 2025, driven by Signatera and Prospera.
- Significantly expanded Signatera's clinical utility and reimbursement, securing new coverage decisions.
Insider Trading
STRONG SELL
9 insiders
100 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.